Related Experiment Video

Updated: Aug 3, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

Aspergillus brain abscess in a patient with acute myeloid leukaemia successfully treated with voriconazole

F Wandroo1, P Stableforth, Y Hasan

  • 1Department of Haematology, Sandwell and West Birmingham Hospital, Lyndon Road, West Bromwich, West Midlands B714HJ, UK. fwandroo@hotmail.com

Clinical and Laboratory Haematology
|April 25, 2006
PubMed

Insights

Cerebral aspergillosis is a deadly fungal infection in immunocompromised patients. Voriconazole, a newer azole, shows promise for treating this condition, offering a potential new treatment option.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Neuroscience

Background:

  • Cerebral aspergillosis presents a significant challenge due to high mortality rates in immunocompromised individuals.
  • Conventional antifungal therapies, including amphotericin-B and itraconazole, demonstrate limited efficacy against this invasive fungal infection of the brain.

Observation:

  • The blood-cerebrospinal fluid barrier poses a challenge for antifungal drug penetration.
  • Newer azole antifungal agents exhibit improved penetration across the blood-cerebrospinal fluid barrier.
  • Effective fungicidal concentrations of newer azoles can be achieved within the central nervous system.

Findings:

  • A patient diagnosed with cerebral aspergillosis achieved successful treatment outcomes.
  • The successful treatment was attributed to the administration of voriconazole, a newer generation azole antifungal medication.

Implications:

  • Voriconazole represents a potential therapeutic advancement for cerebral aspergillosis.
  • The findings suggest that newer azoles could alter the prognosis for patients with this severe fungal infection.
  • Successful voriconazole treatment may offer a new therapeutic strategy for immunocompromised hosts with central nervous system fungal infections.

More Related Videos

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus12:29

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus

Published on: April 19, 2017

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...